Dermsquared

Topical steroids have been the default for pediatric atopic dermatitis (AD) for decades. But with growing concern around topical steroid withdrawal and a new generation of nonsteroidal options reaching the clinic, the conversation is shifting fast.

That's the focus of ‘Targeted Topical Innovations For Your Pediatric Patients’ at Pediatrics360, where Linda F. Stein Gold, MD, and Elizabeth (Lisa) A. Swanson, MD, join moderator Lawrence Eichenfield, MD, to walk through what the latest data says about emerging nonsteroidal topicals in pediatric patients, and how to put it to work in your practice. The session also includes a live Q&A where you can propose your toughest cases to the faculty directly.

June 13, 2026 | 11:05 AM EDT

Earn up to 0.5 𝘈𝘔𝘈 𝘗𝘙𝘈 𝘊𝘢𝘵𝘦𝘨𝘰𝘳𝘺 1 𝘊𝘳𝘦𝘥𝘪𝘵(𝘴)™ for this session, and up to 4.5 CME credits for Parts 1 and 2 of this virtual conference.

Not registered yet? Sign up for Pediatrics360 for FREE at: https://dermsquared.org/conferences/pediatrics360-2026/overview

This activity is supported by educational grants from Arcutis Biotherapeutics, Inc., Incyte and Organon.

This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of the Institute for Continuing Healthcare Education (“Institute”) and CMEsquared®. The Institute is accredited by the ACCME to provide continuing medical education for physicians.

The Institute for Continuing Healthcare Education designates this live conference activity for a maximum of 4.5 𝘈𝘔𝘈 𝘗𝘙𝘈 𝘊𝘢𝘵𝘦𝘨𝘰𝘳𝘺 1 𝘊𝘳𝘦𝘥𝘪𝘵(𝘴)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

The Desert Glow White Party set the tone for the final stretch of PANP360. ✨

Saturday night on the lawn brought hair tinsel installations, branded keychains, and for the bravest amongst us, karaoke with a live band. A fitting send-off into the last day in Scottsdale.

Sunday's GLP-1 Workshop opened with collaborative conversations on GLP-1 receptor agonists in psoriasis management, featuring a patient advocate perspective. The general session closed out with rapid-fire updates across hyperpigmentary disorders, seborrheic dermatitis, scarring hair loss, and dermoscopy, before final remarks from the chairs.

That's a wrap on PANP360 West 2026!

Next stop- we're trading cacti for cobblestones. Boston, August 14–16. Hands-on workshops and refundable registration. Register at: https://bit.ly/3Qcvtlv

Oral isotretinoin has been in use for decades, but many of the questions around dosing, duration, and relapse still come back to the basics.

In this solo “Spilling the Tea” episode of Tea with Dr. D, James Q. Del Rosso, DO, revisits isotretinoin through a longitudinal lens, connecting what we learned early on to how we approach treatment today.

He touches on:
-Why cumulative exposure, not just daily dose, matters for durability nd treatment response
-Why cumulative exposure, not just daily dose, matters for durability
-How lab monitoring has shifted in recent years planning
-How lab monitoring has shifted in recent years

Watch the full episode here: https://dermsquared.com/podcasts/tea-with-dr-d/tea-season-2-episode-7